Search Results

Burden of Current Insulin Therapy and Expectations for Future Insulin Therapy: Results from INBEING, a Web-Based Survey in Japan.

• Authors : Hayashino, Yasuaki; Tsuboi, Satoshi; Yamamoto, Yuiko

Subjects: TYPE 2 diabetes; PHYSICIANS' attitudes; TYPE 1 diabetesJAPAN

• Source: Diabetes Therapy; Dec2024, Vol. 15 Issue 12, p2537-2555, 19p

Record details

Current conditions of use of long‐term care insurance services for home‐based long‐term care recipients who need insulin therapy.

• Authors : Watanabe, Shinobu^1,2; Ito, Tomoko¹; Sugiyama, Takehiro^1,3,4,5

Subjects: *INSULIN therapy; *HOME nursing; *HOME care servicesJAPAN

• Source: Geriatrics & Gerontology International. Mar2023, Vol. 23 Issue 3, p253-255. 3p.

Record details

Reduction of medication errors related to sliding scale insulin by the introduction of a standardized order sheet.

• Authors : Harada, Saki¹; Suzuki, Akio¹ ‐u.ac.jp; Nishida, Shohei¹

Subjects: *HYPOGLYCEMIA; *INSULIN therapy; *MEDICATION error preventionJAPAN

• Source: Journal of Evaluation in Clinical Practice. Jun2017, Vol. 23 Issue 3, p582-585. 4p.

Record details

Japan inc isnt very japanese any longer.

• Authors : Pesek, Willie (AUTHOR)

Subjects: *STAGNATION (Economics); *LABOR costs; *ECONOMIC shockJAPAN

• Source: Bloomberg.com. 1/13/2015, pN.PAG-N.PAG. 1p.

Record details

Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66).

• Authors : Yokoyama H; Araki SI ...

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Insulin*/Insulin*/Insulin*/therapeutic use

• Source: BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2022 May; Vol. 10 (3).Publisher: Published by BMJ in partnership with the American Diabetes Association Country of Publication: England NLM ID: 101641391 Publication Model: Print

Record details

Clinical background of Japanese patients with type 1 diabetes mellitus who have received insulin therapy for 50 years or longer.

• Authors : Otani, Toshika; Kasahara, Tadasu; Miura, Junnosuke

• Source: Diabetology International. October, 2019, Vol. 10 Issue 4, p288, 7 p.

Record details

Utilization patterns of insulin therapy and healthcare services among Japanese insulin initiators during their first year: a descriptive analysis of administrative hospital data.

• Authors : Ikeda, Shunya¹ ; Crawford, Bruce^2,3; Sato, Masayo⁴

Subjects: *INSULIN therapy; *TYPE 2 diabetes treatment; *TYPE 2 diabetes diagnosisJAPAN

• Source: BMC Health Services Research. 1/12/2016, p1-11. 11p. 1 Diagram, 5 Charts, 1 Graph.

Record details

Implementation rate of diabetic self‐management education and support for Japanese people with diabetes using the National Database.

• Authors : Ihana‐Sugiyama, Noriko; Sugiyama, Takehiro; Imai, Kenjiro

Subjects: PEOPLE with diabetes; JAPANESE people; DATABASESJAPAN

• Source: Journal of Diabetes Investigation; Jul2024, Vol. 15 Issue 7, p861-866, 6p

Record details

Long-term (52-week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 study.

• Authors : Araki E; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.; Mathieu C

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy; Benzhydryl Compounds/Benzhydryl Compounds/Benzhydryl Compounds/adverse effects ; Blood Glucose

• Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2021 Jul; Vol. 23 (7), pp. 1496-1504. Date of Electronic Publication: 2021 Mar 15.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

A randomized, placebo-controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control.

• Authors : Kadowaki T; Omarigliptin Study 039 Group

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Double-Blind Method ; Drug Therapy, Combination

• Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2021 Jun; Vol. 23 (6), pp. 1242-1251. Date of Electronic Publication: 2021 Feb 17.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details